ARAIX
Price
$83.27
Change
+$0.11 (+0.13%)
Updated
Jul 2 closing price
Net Assets
2.91B
VMVAX
Price
$103.69
Change
+$1.01 (+0.98%)
Updated
Jul 2 closing price
Net Assets
36.63B
Interact to see
Advertisement

ARAIX vs VMVAX

ARAIX vs VMVAX Comparison Chart in %
View a ticker or compare two or three
VS
ARAIX vs. VMVAX commentary
Jul 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARAIX is a Hold and VMVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VMVAX has more cash in the bank: 36.6B vs. ARAIX (2.91B). VMVAX pays higher dividends than ARAIX: VMVAX (1.88) vs ARAIX (0.11). ARAIX was incepted earlier than VMVAX: ARAIX (15 years) vs VMVAX (15 years). ARAIX (0.70) is less costly to investors than VMVAX (0.07). VMVAX is a more actively managed with annual turnover of: 23.00 vs. ARAIX (17.00). VMVAX has a lower initial minimum investment than ARAIX: VMVAX (3000) vs ARAIX (1000000). VMVAX annual gain was more profitable for investors over the last year : 19.99 vs. ARAIX (13.49). VMVAX return over 5 years is better than : 42.73 vs. ARAIX (-0.77).
ARAIXVMVAXARAIX / VMVAX
Total Expense Ratio0.700.071,000%
Annual Report Gross Expense Ratio0.700.071,000%
Fund Existence15 years15 years-
Gain YTD12.37512.95196%
Front LoadN/AN/A-
Min. Initial Investment1000000300033,333%
Min. Initial Investment IRAN/AN/A-
Net Assets2.91B36.6B8%
Annual Yield % from dividends0.111.886%
Returns for 1 year13.4919.9967%
Returns for 3 years22.3444.6650%
Returns for 5 years-0.7742.73-2%
Returns for 10 years52.95128.2941%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LDVCX22.920.16
+0.70%
AXS FTSE Vntr Cptl RetTrckr C
PIIJX17.620.10
+0.57%
Principal Diversified Intl J
CCCRX41.510.16
+0.39%
Columbia Contrarian Core R
MGORX37.50-0.43
-1.13%
Morgan Stanley Inst Global Opp IR
GBFAX20.29-0.43
-2.08%
VanEck Emerging Markets A